• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Financial Statements
  • | Overview
  • | Corporate Governance
    • | Board Mandate
    • | Board Committee Charters
    • | Whistleblowing Policy
    • | Code of Conduct
  • | Investor Fact Sheet
  • | News Releases
    • | Fiscal 2012
    • | Archive
  • | Financial Statements
    • | Fiscal 2012
    • | Archive
  • | Annual Reports
  • | Regulatory Filings
  • | Analyst Coverage
  • | Presentations
    • | Corporate Presentations
    • | Scientific Presentations
  • | FAQ Investor Relations
  • | Stock Quote
  • | Shareholder Services
  • | Email Alerts
  • | Legal Disclaimer
  • | Contact IR

Financial Statements

Helix BioPharma’s financial statements and related MD&A are archived on this web site for historical purposes only. Specific information included in these documents may change over time, and may or may not be accurate after the date on the documents. Helix BioPharma has no intention and specifically disclaims any duty to update the information in these documents.

Click here to view the current Fiscal 2012.

Click here to view the archive.

 



  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.